At the same time, in DEPDC1B+shCDK1 group, the results showed that the progression was inhibited in HCC cell lines, which suggested the promoting functions of DEPDC1B overexpression on HCC progression may be blocked after CDK1 knockdown. Here, DEPDC1B is linked to hepatocellular carcinoma.